Abstract
Introduction
Breast cancer is increasingly reported in young premenopausal women in Asia. Adjuvant chemotherapy improves survival; however, it has a unique consequence of ovarian failure in premenopausal patients.
Objective
This study’s aim was to find the incidence of chemotherapy-induced ovarian failure (CIOF) and reversible amenorrhea in premenopausal non-metastatic breast cancer patients.
Method
This mixed retrospective and prospective study follows premenopausal breast cancer patients receiving chemotherapy between 2008 and 2012. Patients in the prospective arm were followed up with menstrual history and serum ovarian hormones (follicle-stimulating hormone [FSH] and estradiol) until 1 year post-chemotherapy, and patients in the retrospective arm were contacted for their menstrual history.
Results
The mean age of the 102 subjects was 43.3 years. Of the patients, 93.1 and 77.9 % were amenorrheic at completion of chemotherapy and at 12 months post-chemotherapy, respectively. Of those who developed amenorrhea, 24.6 % regained menstruation, on average after 7.86 (range 1–15) months post-chemotherapy. Age was the only statistically significant risk factor. CIOF and reversible amenorrhea was 57 and 50 % at <35 years, 95 and 31.6 % at 35–45 years, and 97.9 and 14.9 % at >50 years, respectively. The 33 prospective patients’ estradiol and FSH levels seem to correlate well with onset of amenorrhea, with a falling estradiol and rising FSH trend. Tamoxifen use was associated with elevated estradiol levels 1 year post-chemotherapy.
Conclusion
This study found a high incidence of CIOF, with a relatively low rate of reversible amenorrhea. Premenopausal patients should be counselled prior to treatment and education and support provided.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Agarwal G, Pradeep PV, Aggarwal V et al (2007) Spectrum of breast cancer in Asian women. World J Surg 31:1031–1040. doi:10.1007/s00268-005-0585-9
Yip CH, Taib NAM, Mohamed I (2006) Epidemiology of breast cancer in Malaysia. Asian Pac J Cancer Prev 7:269–374
Han H-S, Ro J, Lee KS et al (2009) Analysis of chemotherapy-induced amenorrhea rates by three different anthracycline and taxane containing regimen for early breast cancer. Breast Cancer Res Treat 115:335–342
Goodwin PJ, Ennis M, Pritchard KI et al (1999) Risk of menopause during the first year after breast cancer diagnosis. J Clin Oncol 17:2365–2370
Bakkum-Gamez JN, Laughlin SK, Jensen JR et al (2011) Challenges in the gynecologic care of premenopausal women with breast cancer. Mayo Clin Proc 86:229–240
Omar ZA, Ali ZM, Tamin NSI (eds) (2006) Malaysian cancer statistics: data and figure peninsular Malaysia 2006. National Cancer Registry, Ministry of Health, Putrajaya
Pathy NB, Yip CH, Taib NA et al (2011) Breast cancer in a multi-ethnic Asian setting: results from the Singapore-Malaysia hospital-based breast cancer registry. Breast 20(Suppl 2):S75–S80
Ismael NN (1994) A study on the menopause in Malaysia. Maturitas 19:205–209
Anders C, Marcom PK, Peterson B et al (2008) A pilot study of predictive markers of chemotherapy related amenorrhea among premenopausal women with early stage breast cancer. Cancer Invest 26:286–295
Burger HG, Dudley EC, Robertson DM et al (2002) Hormonal changes in the menopause transition. Recent Prog Horm Res 57:257–275
Sonmezer M, Oktay K (2006) Fertility preservation in young women undergoing breast cancer treatment. Oncology 111:422–434
Reh A, Oktem O, Oktay K (2008) Impact of breast cancer chemotherapy on ovarian reserve: a prospective observational analysis by menstrual history and ovarian reserve markers. Fertil Steril 90:1635–1639
Karkanaki A, Vosnakis C, Panidis D (2011) The clinical significance of anti-mullerian hormone evaluation in gynecological endocrinology. Hormones 10:95–103
Ausmanas MK, Tan DA, Jaisamrarn U et al (2007) Estradiol, FSH and LH profiles in nine ethnic groups of postmenopausal Asian women: the Pan-Asia Menopause (PAM) study. Climacteric 10:427–437
Swain S, Jeong J, Geyer C et al (2010) Longer Therapy, iatrogenic amenorrhea and survival in early breast cancer. New Engl J Med 362:2053–2065
Berliere M, Dalenc F, Malingret N et al (2008) Incidence of reversible amenorrhea in women with breast cancer undergoing adjuvant anthracycline-based chemotherapy with or without docetaxel. BMC Cancer 8:56
Hickey M, Peate M, Saunders CM et al (2009) Breast cancer in young women and its impact on reproductive function. Hum Reprod Update 15:323–339
Hulvat MC, Jeruss JS (2009) Maintaining fertility in young women with breast cancer. Curr Treat Options Oncol 10:308–317
Canada AL, Schover LR (2012) The psychosocial impact of interrupted childbearing in long-term female cancer survivors. Psychooncology 21(2):134–143
Partridge AH, Goldhirsch A, Gelber S et al (2010) Breast cancer in younger women. In: Harris JR, Lippman ME, Morrow M, Osborne CK (eds) Diseases of the breast, 4th edn. Lippincott Williams & Wilkins, Phildelphia
Scanlon M, Blaes A, Gellar M et al (2012) Patient satisfaction with physician discussions of treatment impact on fertility, menopause and sexual health among pre-menopausal women with cancer. J Cancer 3:217–225
Acknowledgments
This study is supported by research grants from the Ministry of Science, Technology and Innovation and the Ministry of Higher Education, Malaysia (UM.C/HIR/MOHE/06).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Tiong, V., Rozita, A.M., Taib, N.A. et al. Incidence of Chemotherapy-Induced Ovarian Failure in Premenopausal Women Undergoing Chemotherapy for Breast Cancer. World J Surg 38, 2288–2296 (2014). https://doi.org/10.1007/s00268-014-2542-y
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00268-014-2542-y